United States Cancer Biomarkers Market Report 2016

October 2016 | 120 pages | ID: UF0C29CDEEDEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cancer Biomarkers

Revenue, means the sales value of Cancer Biomarkers

This report studies sales (consumption) of Cancer Biomarkers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbott Laboratories (U.S.)
• Affymetrix Inc. (U.S.)
• Roche Diagnostics Ltd. (Switzerland)
• Illumina, Inc. (U.S.)
• Qiagen NV (Netherlands)
• Agilent Technologies (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Merck & Co. Inc. (U.S.)
• Becton Dickinson and Company (U.S.)
• Hologic Inc. (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Protein Biomarkers
• Genetic Biomarkers
• Others

Split by applications, this report focuses on sales, market share and growth rate of Cancer Biomarkers in each application, can be divided into

• Diagnostics
• Drug Discovery and Development
• Prognostics
• Risk Assessment
• Others?

Contents

United States Cancer Biomarkers Market Report 2016

1 CANCER BIOMARKERS OVERVIEW

1.1 Product Overview and Scope of Cancer Biomarkers
1.2 Classification of Cancer Biomarkers
  1.2.1 Protein Biomarkers
  1.2.2 Genetic Biomarkers
  1.2.3 Others
1.3 Application of Cancer Biomarkers
  1.3.1 Diagnostics
  1.3.2 Drug Discovery and Development
  1.3.3 Prognostics
  1.3.4 Risk Assessment
  1.3.5 Others?
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Biomarkers (2011-2021)
  1.4.1 United States Cancer Biomarkers Sales and Growth Rate (2011-2021)
  1.4.2 United States Cancer Biomarkers Revenue and Growth Rate (2011-2021)

2 UNITED STATES CANCER BIOMARKERS COMPETITION BY MANUFACTURERS

2.1 United States Cancer Biomarkers Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Biomarkers Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Biomarkers Average Price by Manufactures (2015 and 2016)
2.4 Cancer Biomarkers Market Competitive Situation and Trends
  2.4.1 Cancer Biomarkers Market Concentration Rate
  2.4.2 Cancer Biomarkers Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CANCER BIOMARKERS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Cancer Biomarkers Sales and Market Share by Type (2011-2016)
3.2 United States Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
3.3 United States Cancer Biomarkers Price by Type (2011-2016)
3.4 United States Cancer Biomarkers Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CANCER BIOMARKERS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Cancer Biomarkers Sales and Market Share by Application (2011-2016)
4.2 United States Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CANCER BIOMARKERS MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbott Laboratories (U.S.)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Cancer Biomarkers Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Affymetrix Inc. (U.S.)
  5.2.2 Cancer Biomarkers Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Roche Diagnostics Ltd. (Switzerland)
  5.3.2 Cancer Biomarkers Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Illumina, Inc. (U.S.)
  5.4.2 Cancer Biomarkers Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Qiagen NV (Netherlands)
  5.5.2 Cancer Biomarkers Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Agilent Technologies (U.S.)
  5.6.2 Cancer Biomarkers Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Thermo Fisher Scientific Inc. (U.S.)
  5.7.2 Cancer Biomarkers Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Merck & Co. Inc. (U.S.)
  5.8.2 Cancer Biomarkers Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Becton Dickinson and Company (U.S.)
  5.9.2 Cancer Biomarkers Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Hologic Inc. (U.S.)
  5.10.2 Cancer Biomarkers Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 CANCER BIOMARKERS MANUFACTURING COST ANALYSIS

6.1 Cancer Biomarkers Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cancer Biomarkers

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cancer Biomarkers Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CANCER BIOMARKERS MARKET FORECAST (2016-2021)

10.1 United States Cancer Biomarkers Sales, Revenue Forecast (2016-2021)
10.2 United States Cancer Biomarkers Sales Forecast by Type (2016-2021)
10.3 United States Cancer Biomarkers Sales Forecast by Application (2016-2021)
10.4 Cancer Biomarkers Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Biomarkers
Table Classification of Cancer Biomarkers
Figure United States Sales Market Share of Cancer Biomarkers by Type in 2015
Figure Protein Biomarkers Picture
Figure Genetic Biomarkers Picture
Figure Others Picture
Table Application of Cancer Biomarkers
Figure United States Sales Market Share of Cancer Biomarkers by Application in 2015
Figure Diagnostics Examples
Figure Drug Discovery and Development Examples
Figure Prognostics Examples
Figure Risk Assessment Examples
Figure Others? Examples
Figure United States Cancer Biomarkers Sales and Growth Rate (2011-2021)
Figure United States Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Table United States Cancer Biomarkers Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Biomarkers Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Biomarkers Sales Share by Manufacturers
Figure 2016 Cancer Biomarkers Sales Share by Manufacturers
Table United States Cancer Biomarkers Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 United States Cancer Biomarkers Revenue Share by Manufacturers
Table United States Market Cancer Biomarkers Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Biomarkers Average Price of Key Manufacturers in 2015
Figure Cancer Biomarkers Market Share of Top 3 Manufacturers
Figure Cancer Biomarkers Market Share of Top 5 Manufacturers
Table United States Cancer Biomarkers Sales by Type (2011-2016)
Table United States Cancer Biomarkers Sales Share by Type (2011-2016)
Figure United States Cancer Biomarkers Sales Market Share by Type in 2015
Table United States Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
Table United States Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Biomarkers by Type (2011-2016)
Table United States Cancer Biomarkers Price by Type (2011-2016)
Figure United States Cancer Biomarkers Sales Growth Rate by Type (2011-2016)
Table United States Cancer Biomarkers Sales by Application (2011-2016)
Table United States Cancer Biomarkers Sales Market Share by Application (2011-2016)
Figure United States Cancer Biomarkers Sales Market Share by Application in 2015
Table United States Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
Figure United States Cancer Biomarkers Sales Growth Rate by Application (2011-2016)
Table Abbott Laboratories (U.S.) Basic Information List
Table Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Affymetrix Inc. (U.S.) Basic Information List
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Basic Information List
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Qiagen NV (Netherlands) Basic Information List
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales Market Share (2011-2016)
Table Agilent Technologies (U.S.) Basic Information List
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Merck & Co. Inc. (U.S.) Basic Information List
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Becton Dickinson and Company (U.S.) Basic Information List
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Hologic Inc. (U.S.) Basic Information List
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Biomarkers
Figure Manufacturing Process Analysis of Cancer Biomarkers
Figure Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Cancer Biomarkers
Table Distributors/Traders List
Figure United States Cancer Biomarkers Production and Growth Rate Forecast (2016-2021)
Figure United States Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table United States Cancer Biomarkers Production Forecast by Type (2016-2021)
Table United States Cancer Biomarkers Consumption Forecast by Application (2016-2021)